Recurrent deletion of CHD1 in prostate cancer with relevance to cell invasiveness (original) (raw)

• Bagchi A, Mills AA . (2008). The quest for the 1p36 tumor suppressor. Cancer Res 68: 2551–2556.
  Article CAS PubMed PubMed Central Google Scholar
• Bagchi A, Papazoglu C, Wu Y, Capurso D, Brodt M, Francis D et al. (2007). CHD5 is a tumor suppressor at human 1p36. Cell 128: 459–475.
  Article CAS PubMed Google Scholar
• Berger MF, Lawrence MS, Demichelis F, Drier Y, Cibulskis K, Sivachenko AY et al. (2011). The genomic complexity of primary human prostate cancer. Nature 470: 214–220.
  Article CAS PubMed PubMed Central Google Scholar
• Beroukhim R, Getz G, Nghiemphu L, Barretina J, Hsueh T, Linhart D et al. (2007). Assessing the significance of chromosomal aberrations in cancer: methodology and application to glioma. Proc Natl Acad Sci USA 104: 20007–20012.
  Article CAS PubMed PubMed Central Google Scholar
• Binkley J, Karra K, Kirby A, Hosobuchi M, Stone EA, Sidow A . (2010). ProPhylER: a curated online resource for protein function and structure based on evolutionary constraint analyses. Genome Res 20: 142–154.
  Article CAS PubMed PubMed Central Google Scholar
• Damber JE, Aus G . (2008). Prostate cancer. Lancet 371: 1710–1721.
  Article PubMed Google Scholar
• DeMarzo AM, Nelson WG, Isaacs WB, Epstein JI . (2003). Pathological and molecular aspects of prostate cancer. Lancet 361: 955–964.
  Article CAS PubMed Google Scholar
• Forbes SA, Tang G, Bindal N, Bamford S, Dawson E, Cole C et al. (2010). COSMIC (the Catalogue of Somatic Mutations in Cancer): a resource to investigate acquired mutations in human cancer. Nucleic Acids Res 38: D652–D657.
  Article CAS PubMed Google Scholar
• Gaspar-Maia A, Alajem A, Polesso F, Sridharan R, Mason MJ, Heidersbach A et al. (2009). Chd1 regulates open chromatin and pluripotency of embryonic stem cells. Nature 460: 863–868.
  Article CAS PubMed PubMed Central Google Scholar
• Hall JA, Georgel PT . (2007). CHD proteins: a diverse family with strong ties. Biochem Cell Biol 85: 463–476.
  Article CAS PubMed Google Scholar
• Jemal A, Siegel R, Xu J, Ward E . (2010). Cancer statistics, 2010. CA Cancer J Clin 60: 277–300.
  Article PubMed Google Scholar
• Jones S, Wang TL, Shih Ie M, Mao TL, Nakayama K, Roden R et al. (2010). Frequent mutations of chromatin remodeling gene ARID1A in ovarian clear cell carcinoma. Science 330: 228–231.
  Article CAS PubMed PubMed Central Google Scholar
• Kessenbrock K, Plaks V, Werb Z . (2010). Matrix metalloproteinases: regulators of the tumor microenvironment. Cell 141: 52–67.
  Article CAS PubMed PubMed Central Google Scholar
• Kim JH, Dhanasekaran SM, Mehra R, Tomlins SA, Gu W, Yu J et al. (2007). Integrative analysis of genomic aberrations associated with prostate cancer progression. Cancer Res 67: 8229–8239.
  Article CAS PubMed Google Scholar
• Kwei KA, Kim YH, Girard L, Kao J, Pacyna-Gengelbach M, Salari K et al. (2008). Genomic profiling identifies TITF1 as a lineage-specific oncogene amplified in lung cancer. Oncogene 27: 3635–3640.
  CAS PubMed PubMed Central Google Scholar
• Lapointe J, Li C, Giacomini CP, Salari K, Huang S, Wang P et al. (2007). Genomic profiling reveals alternative genetic pathways of prostate tumorigenesis. Cancer Res 67: 8504–8510.
  Article CAS PubMed Google Scholar
• Lapointe J, Li C, Higgins JP, van de Rijn M, Bair E, Montgomery K et al. (2004). Gene expression profiling identifies clinically relevant subtypes of prostate cancer. Proc Natl Acad Sci USA 101: 811–816.
  Article CAS PubMed PubMed Central Google Scholar
• Mareel M, Leroy A . (2003). Clinical, cellular, and molecular aspects of cancer invasion. Physiol Rev 83: 337–376.
  Article CAS PubMed Google Scholar
• Marfella CG, Imbalzano AN . (2007). The Chd family of chromatin remodelers. Mutat Res 618: 30–40.
  Article CAS PubMed PubMed Central Google Scholar
• Mason SD, Joyce JA . (2011). Proteolytic networks in cancer. Trends Cell Biol 21: 228–237.
  Article CAS PubMed Google Scholar
• Menon T, Yates JA, Bochar DA . (2010). Regulation of androgen-responsive transcription by the chromatin remodeling factor CHD8. Mol Endocrinol 24: 1165–1174.
  Article CAS PubMed PubMed Central Google Scholar
• Nagarajan P, Onami TM, Rajagopalan S, Kania S, Donnell R, Venkatachalam S . (2009). Role of chromodomain helicase DNA-binding protein 2 in DNA damage response signaling and tumorigenesis. Oncogene 28: 1053–1062.
  Article CAS PubMed PubMed Central Google Scholar
• Olshen AB, Venkatraman ES, Lucito R, Wigler M . (2004). Circular binary segmentation for the analysis of array-based DNA copy number data. Biostatistics 5: 557–572.
  Article PubMed Google Scholar
• Robbins CM, Tembe WA, Baker A, Sinari S, Moses TY, Beckstrom-Sternberg S et al. (2011). Copy number and targeted mutational analysis reveals novel somatic events in metastatic prostate tumors. Genome Res 21: 47–55.
  Article CAS PubMed PubMed Central Google Scholar
• Shen MM, Abate-Shen C . (2010). Molecular genetics of prostate cancer: new prospects for old challenges. Genes Dev 24: 1967–2000.
  Article CAS PubMed PubMed Central Google Scholar
• Taylor BS, Schultz N, Hieronymus H, Gopalan A, Xiao Y, Carver BS et al. (2010). Integrative genomic profiling of human prostate cancer. Cancer Cell 18: 11–22.
  Article CAS PubMed PubMed Central Google Scholar
• Varela I, Tarpey P, Raine K, Huang D, Ong CK, Stephens P et al. (2011). Exome sequencing identifies frequent mutation of the SWI/SNF complex gene PBRM1 in renal carcinoma. Nature 469: 539–542.
  Article CAS PubMed PubMed Central Google Scholar
• Wiegand KC, Shah SP, Al-Agha OM, Zhao Y, Tse K, Zeng T et al. (2010). ARID1A mutations in endometriosis-associated ovarian carcinomas. N Engl J Med 363: 1532–1543.
  Article CAS PubMed PubMed Central Google Scholar